Xiaojuan Yang , Shuting Jia , Chao Xia , Yuping Yang
{"title":"发现新的β-碳碱/褪黑素杂交体作为STAT3抑制剂,通过增加DNA损伤治疗肺癌","authors":"Xiaojuan Yang , Shuting Jia , Chao Xia , Yuping Yang","doi":"10.1016/j.bmc.2025.118227","DOIUrl":null,"url":null,"abstract":"<div><div>Based on the facts that significant synergistic effects exist between STAT3 inhibitors and DNA damage agents, we herein designed and synthesized a series of β-carboline/melatonin hybrids as STAT3 inhibitors via increasing DNA damage. Among them, <strong>DT10</strong> exhibited superior <em>in vitro</em> antitumor potency against A549 and HepG2 cells, with IC<sub>50</sub> values of 0.44 and 1.89 μM, respectively. Mechanistic investigations revealed that <strong>DT10</strong> could reduce p-STAT3 levels, inhibit STAT3 nuclear translocation (IC<sub>50</sub> = 2.06 ± 0.55 μM), and upregulate the DNA damage markers γ-H2AX and 53BP1 in A549 cells. Additionally, <strong>DT10</strong> suppressed the migration and promoted the apoptosis of A549 cells. Overall, <strong>DT10</strong> has a strong anticancer effect and is a candidate therapeutic target for human lung cancer.</div></div>","PeriodicalId":255,"journal":{"name":"Bioorganic & Medicinal Chemistry","volume":"127 ","pages":"Article 118227"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Discovery of novel β-carboline/melatonin hybrids as STAT3 inhibitors for the treatment of lung cancer via increasing DNA damage\",\"authors\":\"Xiaojuan Yang , Shuting Jia , Chao Xia , Yuping Yang\",\"doi\":\"10.1016/j.bmc.2025.118227\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Based on the facts that significant synergistic effects exist between STAT3 inhibitors and DNA damage agents, we herein designed and synthesized a series of β-carboline/melatonin hybrids as STAT3 inhibitors via increasing DNA damage. Among them, <strong>DT10</strong> exhibited superior <em>in vitro</em> antitumor potency against A549 and HepG2 cells, with IC<sub>50</sub> values of 0.44 and 1.89 μM, respectively. Mechanistic investigations revealed that <strong>DT10</strong> could reduce p-STAT3 levels, inhibit STAT3 nuclear translocation (IC<sub>50</sub> = 2.06 ± 0.55 μM), and upregulate the DNA damage markers γ-H2AX and 53BP1 in A549 cells. Additionally, <strong>DT10</strong> suppressed the migration and promoted the apoptosis of A549 cells. Overall, <strong>DT10</strong> has a strong anticancer effect and is a candidate therapeutic target for human lung cancer.</div></div>\",\"PeriodicalId\":255,\"journal\":{\"name\":\"Bioorganic & Medicinal Chemistry\",\"volume\":\"127 \",\"pages\":\"Article 118227\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic & Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0968089625001683\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968089625001683","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Discovery of novel β-carboline/melatonin hybrids as STAT3 inhibitors for the treatment of lung cancer via increasing DNA damage
Based on the facts that significant synergistic effects exist between STAT3 inhibitors and DNA damage agents, we herein designed and synthesized a series of β-carboline/melatonin hybrids as STAT3 inhibitors via increasing DNA damage. Among them, DT10 exhibited superior in vitro antitumor potency against A549 and HepG2 cells, with IC50 values of 0.44 and 1.89 μM, respectively. Mechanistic investigations revealed that DT10 could reduce p-STAT3 levels, inhibit STAT3 nuclear translocation (IC50 = 2.06 ± 0.55 μM), and upregulate the DNA damage markers γ-H2AX and 53BP1 in A549 cells. Additionally, DT10 suppressed the migration and promoted the apoptosis of A549 cells. Overall, DT10 has a strong anticancer effect and is a candidate therapeutic target for human lung cancer.
期刊介绍:
Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides.
The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.